Alight (ALIT) news
Recent news
Metalight - expects H1 2026 adj net profit (non-IFRS) of RMB6.0 mln to RMB16 mln
Alight, Inc. (NYSE: ALIT), a leading provider of health, wealth, and leave solutions, reported its first-quarter 2026 financial results on May 5, 2026. The company recorded revenue of $534 million, a 2.6% decline compared to $548 million in the same period of 2025, primarily due to lower net…
AInvest Wire · Aug 14, 2026Alight, Emed join to expand access to GLP-1s for employers
Employers are increasingly seeking ways to manage the rising demand for GLP-1 medications, which have demonstrated effectiveness in treating obesity and related chronic conditions. These medications, including semaglutide (Ozempic®/Wegovy®) and tirzepatide (Mounjaro®/Zepbound®), are associated with…
AInvest Wire · Aug 11, 2026Altigroup Q2 net loss per share from continuing operations $-0.31
Alight, Inc. (NYSE: ALIT) reported net loss per share of $-0.31 for the second quarter of 2025, according to its most recent financial results. This marked a significant decline compared to the prior year period, where the company recorded net loss per share of $-0.01 . The loss was primarily…
AInvest Wire · Aug 10, 2026Alight sees FY revenue $2.08B to $2.10B, estimated $2.15B
AInvest Wire · Aug 4, 2026Alight sees FY adjusted EBITDA $400M to $415M, estimated $438M
AInvest Wire · Aug 4, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.